uniQure
QURE
#5424
Rank
โ‚ฌ1.13 B
Marketcap
18,30ย โ‚ฌ
Share price
-6.20%
Change (1 day)
164.85%
Change (1 year)

Earnings for uniQure (QURE)

Earnings in 2025 (TTM): -โ‚ฌ0.21 Billion

According to uniQure's latest financial reports the company's current earnings are โ‚ฌ15.75 Million. In 2024 the company made an earning of -โ‚ฌ0.21 Billion, an increase over its 2023 earnings that were of -โ‚ฌ0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for uniQure from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.21 Billion-0.53%
2024 -โ‚ฌ0.21 Billion-22.65%
2023 -โ‚ฌ0.27 Billion139.01%
2022 -โ‚ฌ0.12 Billion-138.54%
2021 โ‚ฌ0.28 B-335.29%
2020 -โ‚ฌ0.13 Billion13.88%
2019 -โ‚ฌ0.11 Billion49.51%
2018 -โ‚ฌ71.27 Million4.55%
2017 -โ‚ฌ68.17 Million12.65%
2016 -โ‚ฌ60.52 Million-9.59%
2015 -โ‚ฌ66.94 Million66.95%
2014 -โ‚ฌ40.1 Million30.8%
2013 -โ‚ฌ30.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚ฌ7.07 B-3,768.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚ฌ93.54 Million-51.49%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-โ‚ฌ0.18 Billion-11.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
-โ‚ฌ0.48 Billion 144.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.80 B-4,149.19%๐Ÿ‡ซ๐Ÿ‡ท France
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.58 B-402.24%๐Ÿ‡บ๐Ÿ‡ธ USA